Reditus Space provides sustainable and scalable microgravity access as a service, facilitating in-space manufacturing for advanced materials and drug formulation. The company offers end-to-end services covering launch integration, autonomous in-orbit operations, and controlled reentry for payload recovery. This integrated approach unlocks commercial potential in Low Earth Orbit through reliable access and rapid mission turnaround.
Funding
Funding not disclosed
Founders
Product
Problem
Manufacturing on Earth is constrained by gravity, which introduces defects and limits the purity and uniformity of materials, especially in semiconductors and pharmaceuticals. This impacts the performance and capabilities of advanced technologies and biomedical innovations.
Solution
Reditus Space offers microgravity manufacturing services in Low Earth Orbit (LEO) using fully reusable infrastructure. By eliminating the effects of gravity at the molecular level, Reditus Space enables the production of materials with unparalleled purity and uniformity. This results in enhanced performance and reduced defects in semiconductors, improved protein crystallization and drug formulation in pharmaceuticals, and overall superior material properties compared to Earth-based manufacturing.
Target Audience
Reditus Space targets semiconductor manufacturers, pharmaceutical companies, and research institutions seeking to leverage the benefits of microgravity for advanced material production and biomedical innovations.
Features
- Microgravity environment for manufacturing processes.
- Fully reusable space-based infrastructure.
- Enhanced protein crystallization for pharmaceutical development.
- Superior drug formulation capabilities.
- Production of high-purity, uniform semiconductors.
- Improved material properties at the molecular level.